Pineridge Advisors LLC
- SEC CIK
- 0002012421
- Latest filing
- Nov 4, 2025
VRTX holding history
Vertex Pharmaceuticals Inc in every 13F filed by Pineridge Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
VRTX overviewAll 13F holders of VRTXFull Q3 2025 holdings
- Shares (Q3 2025)
- 0
- Sold out in Q3 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 7
- Since Q4 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2025 | 0 | $0 | 0.0% | −27−100.0% | Sold out | Holders |
| Q2 2025 | 27 | $12.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2025 | 27 | $13.1K | <0.1% | −24−47.1% | Reduced | Holders |
| Q4 2024 | 51 | $20.5K | <0.1% | +24+88.9% | Added | Holders |
| Q3 2024 | 27 | $12.6K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 27 | $12.7K | <0.1% | −2−6.9% | Reduced | Holders |
| Q1 2024 | 29 | $12.1K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 29 | $11.8K | <0.1% | – | No prior filing | Holders |